MYC-family protein overexpression and prominent nucleolar formation represent prognostic indicators and potential therapeutic targets for aggressive high-MKI neuroblastomas: a report from the children’s oncology group

Abstract excerpt

// Risa Niemas-Teshiba 1 , Ryosuke Matsuno 1, 13 , Larry L. Wang 1 , Xao X. Tang 2, 14 , Bill Chiu 3 , Jasmine Zeki 3 , Jeannine Coburn 4 , Kimberly Ornell 4 , Arlene Naranjo 5 , Collin Van Ryn 5 , Wendy B. London 6 , Michael D. Hogarty 7 , Julie M. Gastier-Foster 8 , A. Thomas Look 9 , Julie R. Park 10 , John M. Maris 7 , Susan L. Cohn 11 , Robert C. Seeger 12 , Shahab Asgharzadeh 12 , Naohiko Ikegaki 2 and...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Neuroblastoma Research and Treatments
• Share to Neuroendocrine Tumor Research Advances